-
Infographic: U.S. Public Supports Lockdown
With Covid-19 cases in the U.S. accelerating in the past few weeks, a recent poll shows the public clearly favors a lockdown to stop the rise.
-
Tech, Genomics Companies Form DNA Storage Alliance
Four companies from the computer technology and genomics industries are starting a coalition to advance DNA as a data storage medium.
-
Start-Up Gains Drug Nanoparticle Manufacturing Tech
A new enterprise spun-off from University of Connecticut is acquiring a technology for continuous manufacturing of nanoscale drug particles.
-
Covid-19 Saliva Test Earns FDA Emergency Clearance
A test to detect Covid-19 viruses in saliva rather than nasal swabs received emergency authorization from Food and Drug Administration.
-
Gene-Editing Enzyme Start-Up Gains $65M
A new company creating engineered enzymes for genome editing therapeutics is raising $65 million in its first venture funding round.
-
Personal Cancer Vaccine Induces Tumor Shrinkage
Interim results from a clinical trial show some head and neck cancer patients receiving a personalized vaccine and immunotherapy report tumor shrinkage.
-
Coronavirus Antibody Maker Raises $80M in New Funds
A company developing synthetic antibodies to protect against a range of coronavirus infections, including Covid-19, is raising $80 million in new venture funds.
-
Salk, Energy Utility Partner on Carbon Capture Plants
A California energy utility and Salk Institute are collaborating on engineering new plant varieties that capture and store more carbon dioxide in the ground.
-
FDA Issues Guidance to Boost Clinical Trial Diversity
Food and Drug Administration issued new regulatory guidance designed to enroll clinical trial participants more representative of the populations they claim to serve.
-
Electric Crispr Chip Quickly Detects Covid-19 Virus
An engineering lab developed a chip device that uses gene editing and an electric field to detect viruses responsible for Covid-19 infections.